Tag: sleep apnea

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?

Inspire Medical Systems Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Inspire Medical Systems (NYSE:INSP) a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions...

Inspire Medical Systems Announces Filing of Registration Statement for Proposed Initial Public Offering

Inspire Medical Systems a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for...

6 ASX Medical Device Stocks

These companies are engaged in a wide range of compelling research around everything from respiratory devices and inflatable tissue to...

Sleep Apnea Device Market to Reach $9 Billion by 2024, Report Says

Sleep apnea can result in death, and currently affects more than 18 million Americans, making it a huge opportunity for...

RespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw Conference

RespireRx Pharmaceuticals Inc. (OTCQB:RSPI) (“RespireRx” or the “Company”), a leader in the development of medicines for the treatment of respiratory disorders,...

RespireRx Pharmaceuticals Inc. Files June 30, 2017 Quarterly Report on Form 10-Q And Provides Update

RespireRx Pharmaceuticals Inc. (OTCQB:RSPI) (“RespireRx” or the “Company”), a leader in the development of medicines for the treatment of neurologically controlled...